Conference Presentation, Panel
Shifting from Reactive to Proactive Health Care | Asia Summit 2024
Milken InstituteSung Hee Choe, Binayak Dutta, Amit Kakar, Lance Little, Simranjit Singh, Tracey Woon, Simran Singh
- Healthcare spending is projected to reach approximately $27 billion by 2030, surpassing defense spending as the largest expenditure.
- Demographic shifts indicate that one in four Singaporeans and between one in four to one in five people in Southeast Asian emerging markets will be over age 65 by 2030 and 2050, respectively.
- Colorectal cancer remains the leading cause of cancer incidence and mortality with nearly 4,000 annual cases in Singapore, yet screening compliance stands at only 27% despite life expectancy differing drastically between early (over 90%) and late stages (approximately 14%).
- Asia faces a projected shortfall of almost 18 million healthcare professionals by 2030 and a health protection gap approaching $1 trillion by the end of 2023.
- Approximately 10% to 14% of the population in Greater China, India, and Southeast Asia suffers from non-communicable diseases, driving half a trillion dollars in annual spending on cardiovascular disease and oncology management.
- A significant portion of the population, including up to 60% of younger consumers in Asia, is willing to increase out-of-pocket expenses for better health outcomes, while 51% of Asian consumers express similar willingness.
- Regulatory and policy initiatives are expected to drive early detection paradigms, including Japan's new three-year cancer plan shifting focus from treatment to prevention and Singapore's use of tax benefits, premium discounts, and lifestyle incentives.
- Technological advancements are anticipated to revolutionize care delivery, with AI expected to shift early detection paradigms, whole genome sequencing costs dropping from hundreds of thousands to a few hundred dollars, and quantum computing improving preventive healthcare access.
- Telehealth adoption accelerated during the pandemic with mixed sustainability due to funding reforms, while health knowledge doubling time has compressed from 50 years to approximately 73 days.
- Blood-based liquid biopsies have received FDA approval, self-sampling technology screened nearly 14,000 additional women for HPV in Asia-Pacific, and a recent Japan initiative involving 230 hospitals yielded 12 regulatory approvals within five years.
- Healthcare automation and propensity modeling using health data are expected to free up worker bandwidth for preventive care and personalize insurance pricing, addressing professional shortages and protection gaps.
- Public sentiment regarding health responsibilities varies, with 58% of the general population holding stigmatizing views on hepatitis risk factors, yet a belief persists that the state must provide primary and preventive health while incentivizing chronic caregivers.